Skip to main content
Clinical Trials/CTRI/2021/07/034797
CTRI/2021/07/034797Active, not recruitingPhase 2

Evaluation of soft tissue and crestal bone changes around non submerged platform switch implants placed epicrestal and subcrestal in thin gingival biotypes.

chennu swetha0 sites28 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Active, not recruiting
Sponsor
Enrollment
28

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1.Apparently healthy individuals.
  • 2.Patients with thin gingival biotype (<=2mm).
  • 3.Individuals with adequate bone quality (D2 or D3 type) and volume.
  • 4. Presence of adequate keratinized tissue at the edentulous site.
  • 5.Patients who are willing to give informed consent.

Exclusion Criteria

  • 1.Smokers.
  • 2.Individuals with parafunctional habits.
  • 3.Pregnant and lactating women.
  • 4.Patients taking any medication or drug that could jeopardize treatment outcome.

Investigators

Sponsor
chennu swetha

Similar Trials

Evaluation of soft tissue and crestal bone... | Clinical Trial